C12N2730/10011 - CPC Classification Index

ClassID:

110202 ⎘

C12N2730/10011 - CPC Classification

Classification description:

Reverse transcribing DNA viruses; Details Hepadnaviridae

Sub-classes:

C12N2730/10021 » Viruses as such, e.g. new isolates, mutants or their genomic sequences 0
C12N2730/10022 » New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes 7
C12N2730/10023 » Virus like particles [VLP] 9
C12N2730/10031 » Uses of virus other than therapeutic or vaccine, e.g. disinfectant 0
C12N2730/10032 » Use of virus as therapeutic agent, other than vaccine, e.g. as cytolytic agent 0
C12N2730/10033 » Use of viral protein as therapeutic agent other than vaccine, e.g. apoptosis inducing or anti-inflammatory 0
C12N2730/10034 » Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein 8
C12N2730/10041 » Use of virus, viral particle or viral elements as a vector 0
C12N2730/10051 » Methods of production or purification of viral material 0
C12N2730/10061 » Methods of inactivation or attenuation 0
C12N2730/10071 » Demonstrated in vivo effect 1
C12N2730/10088 » For redistribution 0
C12N2730/10111 » Orthohepadnavirus, e.g. hepatitis B virus 32

Recent Application in this class:

20250297255

SYSTEMS TARGETING TMPRSS4 AND SLC34A2

20220175912

Immunopotentiator, immunotherapeutic pharmaceutical composition and its preparation and use